Bargain Bin
Scan
Bargain Bin
raw scan snapshot — prices as of scan date, not live 43 rows · screens, not recommendations ported fromresearch/classic/scans/2026-04-26-bargain-bin.md
True oversold with quality: HON RSI 32 and ABBV RSI 35 offer best risk/reward; LULU and NKE are speculative rebound plays at -58% and -44% from highs.
| Signal | Reading |
|---|---|
| Overall | 🟢 Genuine oversold opportunities in quality names — but SaaS deep-value traps dominate the list |
| Key insight | HON is the highest-quality RSI<30 + negative SMA20 combo; LULU and NKE are deep brand discounts with structural questions still unresolved |
Filter applied: RSI < 30 AND vsSma20 < 0 (truly oversold and below 20-day MA)
Filtered Bargain List (RSI < 30 AND vsSma20 < 0)
| Stock | Price | 7D | 30D | RSI | vsSma20 | vs SMA200 | 52wk Hi | Status |
|---|---|---|---|---|---|---|---|---|
| HON | $213.17 | -8.1% | -5.6% | 31.9 | -6.2% | +1.4% | -14.1% | 🟢 Oversold |
| ABBV | $198.71 | -3.5% | -3.3% | 35.2 | -4.0% | -7.3% | -18.8% | 🟢 Oversold |
| JNJ | $227.50 | -2.7% | -5.2% | 35.8 | -4.0% | +12.1% | -9.6% | 🟢 Oversold |
| NKE | $44.69 | -2.5% | -15.7% | 35.0 | -2.1% | -30.3% | -44.3% | 🟢 Oversold |
| LULU | $143.80 | -12.9% | -9.4% | 34.0 | -8.9% | -21.5% | -57.7% | 🟢 Oversold |
| SNOW | $134.24 | -18.6% | -23.0% | 34.5 | -14.0% | -36.8% | -52.2% | 🔴 Falling knife |
| ZS | $122.62 | -15.1% | -20.2% | 32.1 | -12.8% | -50.1% | -63.6% | 🔴 Falling knife |
Quality x Discount Ranking (Best to Worst)
Tier 1 — Quality Dip Buys (Highest conviction)
HON — Honeywell | $213.17 | RSI 31.9
- Industrial conglomerate, decades of cash flows, breaking out segment restructuring
- RSI 31.9, -8.1% in 7 days — short-term flush on earnings concern
- Still +1.4% above SMA200 — in secular uptrend, just pulled back
- -14% from 52wk high — not catastrophic
- Dividend payer, quality franchise
- Entry zone: <$210 | Action: ✅ Strong Buy
JNJ — Johnson & Johnson | $227.50 | RSI 35.8
- Healthcare stalwart, clean balance sheet, Talc liability mostly behind it
- RSI 35.8, -5.2% in 30 days — pullback in defensive name
- +12.1% above SMA200 — secular uptrend intact
- -9.6% from 52wk high — shallow dip in quality compounder
- +51% 1Y return despite current weakness
- Entry zone: <$225 | Action: ✅ Strong Buy
ABBV — AbbVie | $198.71 | RSI 35.2
- Pharma compounder, HUMIRA cliff largely absorbed, Skyrizi/Rinvoq ramping
- RSI 35.2, -7.3% below SMA200 — getting stretched below longer-term trend
- -3.3% 30D, -18.8% from 52wk high
- Golden cross active (SMA50 > SMA200 still)
- Dividend aristocrat; 5Y return +115% for a defensive
- Entry zone: <$195 | Action: ✅ Strong Buy
Tier 2 — Speculative Rebound (Brand still matters but thesis impaired)
NKE — Nike | $44.69 | RSI 35.0
- Iconic brand, -44% from 52wk high, -62% from peak in 2022
- CEO transition underway (Elliott Hill), restructuring
- RSI 35 but trend is strong-down, SMA200 -30% above — not in uptrend
- 30D -15.7%, 3M -30.8% — still falling
- Death cross active
- Risk: China slowdown, brand fatigue, tariff exposure on Vietnam mfg
- Entry zone: <$42 | Action: 🔍 Research first — knife falling
LULU — Lululemon | $143.80 | RSI 34.0
- Premium athleisure, -57.7% from 52wk high — massive compression
- RSI 34.0, 7D -12.9%, 3M -25.4% — momentum still negative
- SMA200 -21.5% above current price — major technical damage
- 5Y return -57.8% — underperformed SPY massively
- Death cross active
- Risk: North America comps negative, China rollout slowing
- Entry zone: <$135 | Action: 🔍 Watch — needs stabilization first
Tier 3 — Falling Knives (RSI oversold but quality impaired)
SNOW — Snowflake | $134.24 | RSI 34.5
- Cloud data warehouse, -52% from 52wk high, -37% below SMA200
- Insider selling: -$1.2B (see insider-scan)
- 7D -18.6%, 30D -23% — still in freefall
- CEO transition noise, AI competition from Databricks and BigQuery intensifying
- Action: ❌ Avoid — insider selling + freefall
ZS — Zscaler | $122.62 | RSI 32.1
- Security SaaS, -64% from 52wk high, -50% below SMA200
- Insider selling: -$170M at RSI 32 (see insider-scan — critical red flag)
- 7D -15.1%, 30D -20.2% — catastrophic drawdown
- Action: ❌ Avoid — insider selling validates the breakdown
Extended Scan — Near Bargain (RSI 30-40 with vsSma20 < 0)
| Stock | Price | 7D | 30D | RSI | vsSma20 | Quality | Action |
|---|---|---|---|---|---|---|---|
| WDAY | $119.92 | -13.1% | -10.3% | 38.4 | -6.2% | Medium | 🔍 Watch |
| MCD | $299.36 | -3.0% | -4.0% | 37.8 | -2.2% | HIGH | 📈 Accumulate |
| BRK-B | $469.32 | -1.2% | -1.4% | 39.8 | -1.2% | HIGH | 📈 Accumulate |
| CME | $285.06 | -1.4% | -3.0% | 36.4 | -3.6% | HIGH | 📈 Accumulate |
| LLY | $883.96 | -4.3% | -3.5% | 38.3 | -4.0% | HIGH | 📈 Watch closely |
| TSLA | $352.42 | -2.8% | -10.9% | 39.2 | -4.5% | Medium | 📈 Insider signal |
| OKTA | $67.35 | -20.0% | -12.7% | 39.2 | -10.4% | Medium | 🔍 Watch |
| CRSP | $48.78 | -15.4% | +3.6% | 40.7 | -6.7% | Medium | 📈 Insider buy |
| TEAM | $61.30 | -16.5% | -19.5% | 35.1 | -10.0% | Medium | 🔍 Watch |
| VEEV | $158.45 | -13.3% | -14.5% | 32.9 | -9.4% | Medium-high | 🔍 Watch |
Entry Zones Summary
EXTREME OVERSOLD (RSI < 32) — Capitulation Territory
| Stock | Current | Zone | RSI | 30D | Quality | Action |
|---|---|---|---|---|---|---|
| JNJ | $227.50 | <$225 | 35.8 | -5.2% | HIGH | ✅ Strong Buy |
| HON | $213.17 | <$210 | 31.9 | -5.6% | HIGH | ✅ Strong Buy |
| ABBV | $198.71 | <$195 | 35.2 | -3.3% | HIGH | ✅ Strong Buy |
OVERSOLD (RSI 30-40) — Quality Names Worth Tracking
| Stock | Current | Zone | RSI | 30D | Action | Notes |
|---|---|---|---|---|---|---|
| MCD | $299.36 | <$290 | 37.8 | -4.0% | 📈 Accumulate | Fast food recession-proof |
| BRK-B | $469.32 | <$460 | 39.8 | -1.4% | 📈 Accumulate | Buffett cash fortress |
| CME | $285.06 | <$280 | 36.4 | -3.0% | 📈 Accumulate | Benefits from volatility |
| LLY | $883.96 | <$860 | 38.3 | -3.5% | 📈 Watch | GLP-1 secular thesis |
| NKE | $44.69 | <$42 | 35.0 | -15.7% | 🔍 Research | Turnaround risk/reward |
| LULU | $143.80 | <$135 | 34.0 | -9.4% | 🔍 Watch | Needs stabilization |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| ✅ STRONG BUY | HON <$210, JNJ <$225, ABBV <$195 | Quality + RSI oversold + thesis intact |
| 📈 ACCUMULATE | MCD <$290, BRK-B <$460, CME <$280 | Quality near oversold, DCA opportunity |
| 🔍 WATCH | LLY, NKE, LULU, CRSP, VEEV | Oversold but trend not yet reversed |
| ❌ DON'T BUY | SNOW, ZS | Oversold RSI + insider selling = falling knife |
What Changed vs 2026-04-13
| Stock | Apr 13 RSI | Apr 26 RSI | 30D Change | Note |
|---|---|---|---|---|
| LULU | ~40 | 34.0 | -9.4% | Got worse — more oversold |
| NKE | ~40 | 35.0 | -15.7% | Accelerating lower |
| HON | ~50 | 31.9 | -5.6% | New entry — now properly oversold |
| ABBV | ~47 | 35.2 | -3.3% | Approaching oversold territory |
| SNOW | ~40 | 34.5 | -23.0% | Deteriorating rapidly |
| JNJ | ~48 | 35.8 | -5.2% | Quality dip getting more attractive |
Key Discoveries
| Discovery | Implication |
|---|---|
| HON RSI 31.9 with +1.4% above SMA200 | Rare: oversold but still in secular uptrend = quality dip |
| JNJ RSI 35.8 with +12.1% above SMA200 | Defensive quality at its most interesting level in months |
| SNOW/ZS oversold RSI but insiders selling | RSI oversold ≠ buy when insiders are distributing — different signal |
| BRK-B RSI 39.8 at $469 | Buffett's fortress quietly pulling back to attractive zone |
Mistakes (Don't Repeat)
| Mistake | Lesson |
|---|---|
| Buying oversold SaaS without checking insider data | SNOW at RSI 34 looks like a buy — $1.2B insider selling says otherwise |
Open Questions
Related
6 eventsNo direct external sources are attached to this read.